ISPOR 12th Annual European Congress Scientific Awards Winners

By Stephen Priori, Director, ISPOR Publications

The ISPOR Best Research Podium and Poster Presentation Awards were established in 1998 to recognize the scientific merit of podium and poster presentations of the ISPOR Annual International Meetings, Annual European Congresses, and Asia-Pacific Conferences. At this year's European Congress, the ISPOR Awards Committee evaluated 75 podium presentations and over 1,000 poster presentations.

Evaluations of scientific merit were based upon the following criteria:

  • Background provides appropriate perspective/context for the subject
  • Objectives / research questions are clearly stated
  • Research design / methods / modeling is appropriate and transparent (scores on this will determine winners in case of ties)
  • Data sources and/or sampling procedures are clear and appropriate
  • Data analyses are appropriate
  • Research objectives are met/addressed
  • Implications of findings are discussed
  • Factual information is kept separate from interpretations or implications
  • Abstract is presented in an unbiased manner
  • Clarity of presentation


THE RECIPIENTS  ARE: . . .

ISPOR Best Podium Research Presentation Awards

VA6
INTEGRATED DYNAMIC TRANSMISSION/COST-EFFECTIVENESS MODEL FOR INFLUENZA A AND B PART I: DEVELOPMENT OF AN INTEGRATED MODEL

Pitman RJ1, Leeuwenkamp O2

1Oxford Outcomes Ltd, Oxford, Oxfordshire, UK, 2MedImmune, Cambridge, Cambridgeshire, UK


VA2
A HEALTH ECONOMIC EVALUATION OF A NEW HERPES ZOSTER (HZ) VACCINE FOR THE PREVENTION OF HZ AND POST-HERPETIC NEURALGIA (PHN) IN BELGIUM

Annemans L1, Papageorgiou M2, Martin M3, Bresse X4

1Ghent University, Ghent, Belgium, 2i3 Innovus, Athens, Greece, 3i3 Innovus, Uxbridge, Middlesex, UK, 4Sanofi Pasteur MSD, Lyon, France


PR2
DEVELOPMENT AND PSYCHOMETRIC PROPERTIES OF A PEDIATRIC PERCEIVED COGNITIVE FUNCTION ITEM BANK (PEDSPCF)

Lai JS1, Zelko F2, Butt Z1, Cella D1, Magasi S1, Goldman S2
1Northwestern University, Chicago, IL, USA, 2Children's Memorial Hospital, Chicago, Chicago, IL, USA

 

ISPOR Best New Investigator Podium Presentations Award

MO12
COMPARISON OF THREE META-MODELS FOR UNCERTAINTY ANALYSIS

Lieuw On MML1, Heeg BMS2, De Charro F2, van Hout BA3

1Pharmerit, Rotterdam, Zuid-Holland, The Netherlands, 2Pharmerit Europe, Rotterdam, The Netherlands, 3Pharmerit Ltd, York, North Yorkshire, UK

CN7
TREATMENT VARIATION COMPLICATES REAL-WORLD PHARMACOECONOMICS: DAILY CLINICAL PRACTICE OF BORTEZOMIB IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA

Franken M1, Gaultney J1, Huijgens P2, Redekop W1, Uyl-de Groot C1

1Erasmus University Medical Center, Rotterdam, The Netherlands, 2VU University Medical Center, Amsterdam, The Netherlands

VA1
SEVEN, TEN OR THIRTEEN? THE COST-UTILITY OF INFANT VACCINATION WITH A 7, 10- OR 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN THE NETHERLANDS

Vemer P1, de Greeff SC2, Schouls LM2, Al MJ1, de Melker H2

1Erasmus MC, Rotterdam, The Netherlands, 2National Institute for Public Health and Environment (RIVM), Bilthoven, The Netherlands

ISPOR Best Student Podium Research Presentations Awards

VA5
INDIVIDUALLY-BASED DYNAMIC MODELING OF INFECTIOUS DISEASES: COST-EFFECTIVENESS OF ADOLESCENT PERTUSSIS BOOSTER VACCINATION FOR THE NETHERLANDS

de Vries R, Postma M

University of Groningen, Groningen, The Netherlands

MO7
EVALUATION OF A BAYESIAN COMPREHENSIVE DECISION-ANALYTICAL MODELLING FRAMEWORK IN CHRONIC HEPATITIS C

Cawston H1, Aballéa S2, Cure S1
1i3 Innovus, Uxbridge, UK, 2i3 Innovus, Nanterre, France

VA8
HOW SHOULD HEALTH GAINS OF VACCINATION STRATEGIES BE DISCOUNTED?

Westra TA1, Rogoza R2, Daemen T1, Wilschut JC1, Postma MJ3

1University Medical Center Groningen, Groningen, The Netherlands, 2i3 Innovus, Burlington, ON, Canada, 3University of Groningen, Groningen, The Netherlands

ISPOR Best Paper Poster Research Presentations Awards

PCV62
PULMONARY ARTERIAL HYPERTENSION (PAH) COST OF ILLNESS IN THE U.S. PRIVATELY-INSURED POPULATION

Kirson NY1, Birnbaum HG1, Ivanova JI2, Schiller M1, Waldman T1, Williamson T3

1Analysis Group, Inc., Boston, MA, USA, 2Analysis Group, Inc., New York, NY, USA, 3Bayer HealthCare Pharmaceuticals, Wayne, NJ, US

PMC11
IMPUTE INCOMPLETE PATIENT-LEVEL MEDICAL COSTS

Guan S1, Peeters P2, Pedotti P1, Van Engen AK1

1Quintiles Consulting, Hoofddorp, The Netherlands, 2Quintiles Consulting, Levallois-Perret, France

PMC9
REDUCING BIAS IN A RETROSPECTIVE CASE-CONTROL STUDY: AN APPLICATION OF PROPENSITY SCORE MATCHING
.

Exuzides A1, Colby C1, Goldman J2, Waaler A3

1ICON Clinical Research, San Francisco, CA, USA, 2ICON Medical Imaging, San Francisco, CA, USA, 3GE Healthcare, Horten, Norway

ISPOR Best New Investigator Poster Research Presentations Awards*

PCV63
COST OF CARDIOVASCULAR DISEASE IN KOREA: INCIDENCE-BASED APPROACH

Lee YS1, Kim BJ2, Rha SW3, Ham GR1, Seo HS1, Moon OR4

1PrimeCore Consulting, Seoul, South Korea, 2Kangbuk-Samsung Medical Center, Seoul, South Korea, 3Korea University Guro Hospital, Seoul, South Korea, 4Inje Graduate School of Public Health, Seoul, South Korea

 

PGI12
RESOURCE UTILIZATION AND DIRECT MEDICAL COST OF CHRONIC HEPATITIS C (CHC) IN THAILAND: A HEAVY BUT MANAGEABLE ECONOMIC BURDEN

Thongsawat S1, Piratvisuth T2, Pramoolsinsap C3, Chutaputti A4, Tanwandee T5, Sukarom I6, Tinmanee S6

1Maharaj Nakorn Chiang Mai Hospital, Chiang Mai University, Chiang Mai, Thailand, 2Songklanagarind Hospital, Prince of Songkla University, Songkla, Thailand, 3Ramathibodi Hospital, Mahidol University, Bangkok, Thailand, 4Phramongkutklao Hospital, Bangkok, Thailand, 5Siriraj Hospital, Mahidol University, Bangkok, Thailand, 6Roche Thailand Ltd, Bangkok, Thailand

PDB1
A COMPARISON OF CLINICAL EFFICACY OF INSULIN GLARGINE ADDED TO ORAL ANTIDIABETIC DRUGS VS PREMIXED INSULINS ALONE IN THE TREATEMENT OF TYPE-2 DIABETES MELLITUS

Rogoz A1, Kucia K1, Skowron M1, Rys P1, Siejka S1, Palka I1, Gierczynski J2, Plisko R1, Wladysiuk M1

1HTA Consulting, Krakow, Poland, 2Sanofi-Aventis sp. z o.o, Warszawa, Poland

PIN8
BUDGET-IMPACT ANALYSIS OF ADDING THE NEW 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION (PHID-CV) TO ROUTINE INFANT VACCINATION IN CANADA

Ismaila AS1, Pereira JA1, Robson RC1, Talbird SE2, Standaert BA3, Rawson NS1

1GlaxoSmithKline, Mississauga, ON, Canada, 2RTI Health Solutions, Research Triangle Park, NC, USA, 3GlaxoSmithKline Biologicals, Rixensart, Belgium

 

 

*Due to unbreakable tie in this category, there were 4 recipients awarded in this category

ISPOR Best Student Poster Research Presentations Awards

PRS17
COST-EFFECTIVENESS OF RESPIRATORY SYNCYTIAL VIRUS PROPHYLAXIS WITH PALIVIZUMAB FROM THE PERSPECTIVE OF A SOUTHERN US MEDICAID AGENCY

Hampp C, Kauf TL, Saidi A, Winterstein AG

University of Florida, Gainesville, FL, USA

 

PCN27
TRENDS IN COLORECTAL CANCER SCREENING (CRC) PATTERNS AMONG COMMUNITY DWELLING MEDICARE BENEFICIARIES

Maneno M1, Lee E1, Zuckerman IH2, Simoni-Wastila L2, Daniel M1, Green PM3, Adderley-Kelly B3, Wutoh AK4

1Center for Minority Health Services Research, Dept of Clinical & Administrative Pharmacy Sciences, Howard University, Washington, DC, USA, 2Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, MD, USA, 3College of Pharmacy, Nursing, and Allied Health Science, Howard University, Washington, DC, USA, 4Center for Minority Health Services Research, Dept of Clinical & Administrative Pharmacy Sciences, Howard University, Washington, DC, USA

PMS59
THE CLINICAL AND ECONOMIC BURDEN OF NONADHERENCE WITH OSTEOPOROSIS MEDICATIONS

Hiligsmann M, Rabenda V, Bruyère O, Reginster JY

University of Liège, Liège, Belgium

A special thanks goes to all the judges, the ISPOR Annual European Congress Research Awards Chairs as well as the ISPOR Awards Committee Chair who volunteered their time and efforts in selecting the winners.

ISPOR ANNUAL EUROPEAN CONGRESS RESEARCH AWARDS CHAIRS:

 

Podium: Carole Longson PhD, Director, NICE, London, UK

 

Poster: Matt Stevenson PhD, Technical Director, ScHARR TAG, Sheffield, UK

 

ISPOR JUDGES: Linda Abetz-Webb, Saurabh Aggarwal, Bulent Akmaz, Fahimah Al Awadhi, Olubodun Emmanuel Babatunde, Rajesh Balkrishnan, Sanjeev Balu, Helena Bargiel, Eric Baseilhac, Gustaf Befrits, Matthew Bending, Gaizka Benguria-Arrate, Gilles Berdeaux, Claire Bernard, Murtuza Bharmal, Matthias Bischof, Marja Blom, Lindsay Bockstadt, Isabelle Borget, Bernd Brüggenjürgen, Hsing-Yi Chang, Irene Chen, Otavio, Clark, Marta Contente, Thomas Daniel, Erwin De Cock, Regina Demlova, Sarah Dewilde, Jenifer Ehreth, Gottfried Endel, Alex Exuzides, Walid         Fakhoury, Laia          Febrer, Samuel Fourie, Frank-Ulrich Fricke, Gisselle Gallego, Cindy Gao, Dave Garrell, William Gerth, Beatrice Gueron, Taru Hallinen, Jeff Hallowell, Michiel Hemels, Lars Holger Ehlers, Sergio Iannazzo, Shrividya Iyer, Karina, Jahnz-Rozyk, Ian Johnson, Sherif Kamal, Victor Kiri, Chris Knight, Kathrin Kreyenberg, Eui Kyung, Agathe Le Lay, Lauren Lent, Ricardo Letizia, Hong Li, Nicky Liebermann, Kristy Lim, Joanna Lis, Juan Luis Lopez Belmonte, Monique Martin, Clare McGrath, Goran Medic, Patrick       Mollon, Axel Muhlbacher, Fredrik Nilsson, Abayomi Olaleye, Ulrike Osowski, Aurelie Pacull, Robert Petrella, Olaf Pirk, Pedro Plans, Robert Plisko, Yogesh Punekar, Ken Redekop, Matt Reynolds, Lance Richard, Miny Samuel, Cate Scott, Julian Shepelev, Chris Skedgel, Anne Solesse, Jane Speight, Peter Sun, Darren Talbot, Yot Teerawattananon, Ignacio Tellez, Patrick Tilleul, Kaan Tunceli, MarcoTurini, Carin Uyl, Henri, Vanden Baviere, Pepijn Vemer, Birgitta von Scheele, Samuel Wagner, Silky Webb, Adele Weston, Craig White, William Willis, Jerome Wilson, Koo Wilson, Rose Yeh, Emre Yucel, Nader Zaidan, James Zhang, Myriam Zylberman

 

 

Return to ISPOR Awards Index Page | 12th Annual European Congress Main Page